COPD & Asthma
Trelegy Ellipta Assistance Programs & Grants in Utah
Assistance information last verified: August 2026
Some help exists, but every charity fund we checked was closed. GSK's patient assistance program accepts Medicare Part D patients who have already paid $600 out of pocket for prescriptions this year and meet its income limits — though GSK does not publish a list of covered medicines, so confirm Trelegy by phone. The Trelegy savings card excludes Medicare. TotalAssist and HealthWell both list Trelegy, but their COPD and asthma funds were closed to new applicants when we checked. Extra Help is the route that does not depend on a fund balance. Financial assistance may be available through charitable foundations, manufacturer programs, Medicare's Extra Help program, or other assistance resources. Availability and eligibility change frequently — the information on this page was verified in August 2026.
Can I get help paying for Trelegy Ellipta?
Some help exists, but every charity fund we checked was closed. GSK's patient assistance program accepts Medicare Part D patients who have already paid $600 out of pocket for prescriptions this year and meet its income limits — though GSK does not publish a list of covered medicines, so confirm Trelegy by phone. The Trelegy savings card excludes Medicare. TotalAssist and HealthWell both list Trelegy, but their COPD and asthma funds were closed to new applicants when we checked. Extra Help is the route that does not depend on a fund balance.
- GSK Patient Assistance Program: free GSK medicines for eligible patients; Medicare Part D enrollees qualify after paying $600 for prescriptions in the current calendar year, with income at or below $47,880 (one person) or $64,920 (two). Trelegy's inclusion is implied but not listed — call 1-866-728-4368 to confirm.
- Trelegy savings offer: commercial insurance only — excludes Medicare Part B and Part D, Medicaid, Medigap, VA and TRICARE.
- No manufacturer cash-price or free-trial route: GSK's Direct to You program does not include Trelegy, and GSK says it is not currently offering free trials.
- Charitable grants: TotalAssist's COPD and Asthma funds and HealthWell's Asthma and COPD – Medicare Access funds all list Trelegy and were all closed on August 26, 2026. Good Days has no lung fund.
- Medicare: negotiated Part D price of $175 (30-day) starts January 1, 2027; Extra Help can cut a covered brand copay to about $12.65 if you qualify.
1 of the 6 programs we checked for Trelegy Ellipta was accepting applications when verified in August 2026.
About Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol)
Trelegy Ellipta is a once-daily maintenance inhaler that combines an inhaled corticosteroid (fluticasone furoate) with two long-acting bronchodilators (umeclidinium and vilanterol) for COPD and for asthma in adults. It is not a rescue inhaler.
Approved uses
- Long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, in adults (100/62.5/25 mcg strength)
- Long-term maintenance treatment of asthma in patients 18 and older (100/62.5/25 or 200/62.5/25 mcg)
- Not for the relief of sudden breathing problems — a rescue inhaler is still needed
Manufacturer: GSK (GlaxoSmithKline)
Why Trelegy Ellipta can be expensive on Medicare
Trelegy Ellipta is a brand-name inhaler with no FDA-approved generic. GSK lists its price at $697.73 for a 30-day supply as of January 1, 2026, and Part D plans usually place it on a brand tier with a copay or coinsurance every month until you reach the $2,100 annual out-of-pocket cap. A generic application was accepted for FDA review in January 2026 but had not been approved when we checked.
Medicare coverage context
Trelegy Ellipta is generally covered under Medicare Part D and Medicare Advantage drug plans, sometimes with prior authorization or step therapy versus other inhalers. It was selected for the second round of Medicare drug price negotiation: CMS reports a negotiated price of $175 for a 30-day supply that takes effect January 1, 2027 (against a $654 list price in 2024). That price is what plans pay from 2027 — your copay still depends on your plan's tier and cost-sharing, and for the rest of 2026 the negotiated price does not apply.
Check typical Part D coverage · Estimate your drug costs · Compare Part D plans in Vernal
Trelegy Ellipta assistance options at a glance
Every program we checked, what kind of help it is, whether people with Medicare can use it, and its status when we verified it. A medication being listed by a program is not the same as the program accepting applications.
About the income limits below: Income limits can differ between assistance programs even when both describe their eligibility as the same percentage of the federal poverty level. The dollar limits shown here come from each program's own published income table, and each program decides which year's poverty guidelines that table is built from and when it takes effect. Treat the figures as belonging to the program they are listed under — they are not interchangeable, and only the program can tell you which table it is applying to your application today.
| Program | Type of help | People with Medicare | Status (August 2026) |
|---|---|---|---|
| GSK Patient Assistance Program | Manufacturer patient assistance | with conditions | Check current availability |
| Trelegy savings offer (pay as little as $0) | Commercial copay / savings card | not eligible | Accepting applications |
| GSK Direct to You (cash-pay pharmacy) — Trelegy not offered | Manufacturer self-pay pricing | not stated | No program found |
| TotalAssist — COPD and Asthma funds | Charitable grant | may apply | Closed to new applicants |
| HealthWell Foundation — Asthma and COPD – Medicare Access funds | Charitable grant | may apply | Closed to new applicants |
| Good Days | Charitable grant | not stated | No program found |
| Medicare Extra Help (Part D Low-Income Subsidy) | Government program | may apply | Accepting applications |
Manufacturer programs from GSK (GlaxoSmithKline)
A patient assistance program (free or low-cost drug by income) is not the same as a copay card (a commercial discount that usually excludes Medicare). Both are listed so you can see which one applies to you.
Manufacturer patient assistance
GSK Patient Assistance Program
GSK Patient Access Programs Foundation
Status: The program was accepting applications on August 26, 2026, but GSK publishes no covered-medicine list. Trelegy's inclusion is implied — GSK's own Trelegy pricing page sends Medicare and uninsured patients to this program's eligibility check, and the application excludes only Nucala, Benlysta and oncology products — but it is not stated. Confirm by phone before you gather paperwork.
GSK's charitable foundation ships eligible patients up to a 90-day supply of their GSK medicine at no cost, with free refills for the rest of the calendar year. It is a paper application you can complete yourself.
If you have Medicare: GSK's Medicare Part D rule: you must have a Medicare prescription drug plan and "have paid a total of $600 for prescriptions in the current calendar year" (premiums and family members' costs do not count), plus meet the income limits. No Extra Help denial letter is mentioned. Part D patients must re-apply every calendar year once they have again spent $600.
What it can cover: The GSK medicine at no cost — a supply of up to 90 days shipped after approval, then refills through the end of the calendar year.
Who may qualify
- Live in the United States or Puerto Rico
- Medicare Part D plan, and $600 already paid for prescriptions through that plan in the current calendar year (uninsured applicants qualify without the spending rule)
- Maximum annual gross household income: $47,880 for one person, $64,920 for two, $81,960 for three, $99,000 for four (add $17,040 per additional person; higher limits in Alaska and Hawaii)
- A signed original prescription for the GSK medicine
What the application asks for
- Completed and signed application (the last page must be signed and dated)
- Signed original prescription — faxed prescriptions count only if faxed directly from the prescriber's office
- Part D applicants: all pages of your most recent Part D plan statement (Explanation of Benefits) showing $600 paid for prescriptions this calendar year; call GSK if you cannot get one
- Part D applicants: a copy of your Part D drug-plan card (not the original) and your Medicare Beneficiary Identifier (MBI)
- Household size and current annual household income
How to apply
Confirm Trelegy is covered by calling 1-866-728-4368 (Monday–Friday, 8am–8pm ET). Then download the non-vaccine application, complete and sign it, attach the prescription and Part D documents, and mail it to GSK Patient Assistance Program, P.O. Box 220590, Charlotte, NC 28222-0590, or fax it to 1-855-474-3063. GSK notifies you by letter whether you are enrolled. There is no fee.
Commercial copay / savings card
Trelegy savings offer (pay as little as $0)
GSK
Status: Active for commercially insured patients; the offer expires December 31, 2026 and covers up to 12 uses (each 30-day supply counts as one use).
A commercial copay offer: eligible commercially insured patients pay as little as $0 per 30-, 60- or 90-day supply, with a maximum saving of the wholesale acquisition cost less $35 per month.
If you have Medicare: GSK's terms: patients "are not eligible for this program if they are covered by any federal or state prescription insurance program. This includes patients enrolled in Medicare Part B, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD) programs or TRICARE." Medicare-eligible retirees on an employer group waiver plan are also excluded.
Who may qualify
- Commercial (private or employer) prescription insurance that does not cover the full cost
- Not enrolled in any federal or state prescription program
How to apply
Commercially insured patients activate the offer at trelegy.com. Not applicable to Medicare beneficiaries.
Manufacturer self-pay pricing
GSK Direct to You (cash-pay pharmacy) — Trelegy not offered
GSK (fulfilled by Alto Pharmacy)
Status: GSK's cash-pay program lists Advair, Anoro Ellipta, Arnuity, Incruse Ellipta, Ventolin and others — but not Trelegy — on August 26, 2026. GSK also states it is "not currently offering any free trial offers."
An honest negative: there is no manufacturer cash price or free trial for Trelegy Ellipta. GSK's published list price for a 30-day supply was $697.73 as of January 1, 2026.
If you have Medicare: Not applicable — Trelegy is not part of the program. (The program is for people not using insurance.)
How to apply
Not applicable. If GSK adds Trelegy to Direct to You, the product list on the page below will show it.
Charitable grants for Trelegy Ellipta
We could not identify a currently open charitable fund covering Trelegy Ellipta. It is listed by TotalAssist (COPD and Asthma funds, plus their health-equity variants) and by HealthWell (Asthma and COPD – Medicare Access funds), but every one of those funds was closed to new applicants on August 26, 2026. Good Days has no lung fund. Being listed is not the same as being open — sign up for alerts so you hear when one reopens. The routes that do not depend on a fund balance are the GSK Patient Assistance Program and Medicare Extra Help.
Charitable grant
TotalAssist — COPD and Asthma funds
Patient Advocate Foundation · Chronic obstructive pulmonary disease (COPD) · Asthma · COPD health equity · Asthma health equity
Status: All four funds that list Trelegy Ellipta were closed to new applicants on August 26, 2026. The two health-equity funds additionally require a home zip code in a designated social-vulnerability county.
Trelegy Ellipta is on the approved-medication list of TotalAssist's COPD and Asthma funds (and their health-equity variants). A listing is not an open fund — each was closed when we checked. Sign up for notifications; TotalAssist has no waitlist or queue.
If you have Medicare: These funds require government insurance (Medicare, Medicaid or TRICARE) that covers your qualifying expenses.
What it can cover: When open: $1,200 guaranteed award, $3,500 maximum, for medication copays, coinsurance, deductibles and health-insurance premiums. One grant per condition.
Who may qualify
- Confirmed COPD diagnosis (codes J42–J44.9) or asthma diagnosis (J45.20–J45.998, J82.83), in treatment or starting within 60 days
- Government-insured coverage (Medicare, Medicaid or TRICARE) that covers your qualifying expenses
- Household income at or below 500% of the federal poverty level, adjusted for your regional cost-of-living index
- Confirmed diagnosis matching the fund, and in treatment (or starting within 60 days, or treated in the past 6 months)
- Legal U.S. resident receiving treatment in the U.S. or a U.S. territory
What the application asks for
- Contact information and Social Security number (or alien number)
- Annual household income (for pre-screening; proof of income due within 30 days of approval)
- Health insurance carrier, plan type, policy ID and group number; Medicare supplement or secondary insurance if you have one
- Copay or coinsurance amounts
- Your provider's name and contact information, diagnosis (exact date if within 6 months), prescribed medications and treatment plan
How to apply
Sign up for fund notifications (text, email or automated call) at totalassist.org/notify. When a fund opens: You (the patient) apply online — it takes about 15 minutes and you learn immediately whether you are approved — or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis and treatment plan directly with your provider and verifies income automatically; you have 30 days after approval to provide proof of income.
Charitable grant
HealthWell Foundation — Asthma and COPD – Medicare Access funds
HealthWell Foundation · Asthma · Chronic Obstructive Pulmonary Disease – Medicare Access
Status: Both funds were "temporarily closed to new patients due to lack of sufficient funding" on August 26, 2026. Trelegy Ellipta is on each fund's covered-medication list.
HealthWell lists Trelegy on its Asthma fund and its COPD – Medicare Access fund. HealthWell states that closed funds reopen as funding is replenished and offers real-time alerts for each fund.
If you have Medicare: HealthWell requires insurance that covers part of the drug; Medicare qualifies. The COPD fund is a Medicare Access fund — for Medicare patients only — and premium assistance through either fund requires Medicare Part B.
What it can cover: When open: Asthma up to $4,500; COPD – Medicare Access up to $3,250 (HealthWell forecasts an average grant of about $1,500). Both funds allow household income up to 500% of the federal poverty level.
Who may qualify
- Insurance (including Medicare) that covers part of the cost of Trelegy
- Household income up to 500% of the federal poverty level (adjusted for household size and cost of living)
- Asthma or COPD diagnosis, verified by your provider; the COPD fund requires Medicare
What the application asks for
- Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
- Social Security number (used to prevent duplicate applications)
- Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
- Treatment in the United States
How to apply
When a fund is open, apply online or by phone; your provider verifies the diagnosis by signature. When a fund is closed, sign up for that fund's real-time alerts — HealthWell says replenished funds reopen "as quickly as possible."
Charitable grant
Good Days
Good Days
Status: Good Days lists no COPD, asthma or general respiratory program — its only lung-related fund is pulmonary arterial hypertension (checked August 26, 2026).
An honest negative: we looked, and there is no Good Days program covering Trelegy's diagnoses.
If you have Medicare: Not applicable — no matching program.
How to apply
Not applicable.
How to apply for Trelegy Ellipta assistance
The written steps are complete on their own; the video above will walk through the same process when it is published.
-
Step 1 — Find the applicable assistance program
For Trelegy Ellipta in August 2026 the realistic order is manufacturer program → Extra Help, because no charity fund for COPD or asthma is open.
- On Medicare Part D and already $600 into prescription spending this year → GSK Patient Assistance Program (confirm Trelegy by phone first).
- Limited income and resources → Medicare Extra Help through Social Security.
- COPD or asthma diagnosis → sign up for TotalAssist and HealthWell fund alerts (all closed when checked).
- Commercial insurance instead of Medicare → the Trelegy savings offer (Medicare enrollees cannot use it).
-
Step 2 — Check whether applications are currently open
Trelegy appears in TotalAssist's medication index and on HealthWell's fund pages, but a listing does not mean funding is available. On the day we checked, none of those funds was open. Funding can change without notice.
- GSK PAP: gskpaf.org shows the current application; call 1-866-728-4368 to confirm Trelegy is covered.
- TotalAssist: totalassist.org/funds shows "Open" or "Closed" for the COPD and Asthma funds.
- HealthWell: the Disease Funds page shows each fund's status; closed funds reopen as money is replenished.
-
Step 3 — Check eligibility
The GSK rules are specific for Medicare patients — read them before you gather paperwork:
- GSK PAP: a Medicare Part D plan; $600 already paid for prescriptions through that plan this calendar year (not premiums, not family members' costs); household income at or below $47,880 (one person) or $64,920 (two people).
- TotalAssist (when open): government insurance covering Trelegy; income at or below 500% FPL adjusted for local cost of living; a COPD or asthma diagnosis in treatment.
- HealthWell (when open): insurance covering part of the drug; income up to 500% FPL; the COPD fund is Medicare-only.
- Extra Help: income below about $23,940 a year (one person) or $32,460 (couple) and countable resources limited to $18,090 or $36,100 in 2026.
-
Step 4 — Gather your information
The GSK application is a paper form with attachments, so collect these first:
- Your most recent Part D plan statement (Explanation of Benefits) — every page — showing $600 paid for prescriptions this year. If you cannot get one, GSK will help you identify other proof.
- A copy of your Part D drug-plan card and your Medicare Beneficiary Identifier (the number on your Medicare card).
- A signed original prescription for Trelegy from your prescriber (or have the office fax it directly to GSK with a cover sheet).
- Household size and current annual household income.
- Names and phone numbers of anyone you want authorized to speak to GSK on your behalf.
-
Step 5 — Complete the application
Who fills out what:
- GSK PAP: you complete Section 1, sign and date the last page, attach the prescription and Part D documents, and mail or fax the packet yourself — no prescriber section to chase. Keep copies; originals are not returned.
- TotalAssist (when open): you apply online in about 15 minutes or by phone; PAF verifies your diagnosis with your provider.
- Extra Help: you (or someone helping you) apply through Social Security — online, by phone at 1-800-772-1213, or in person. It is free.
-
Step 6 — Submit and wait for a determination
What to expect:
- GSK PAP: you receive a letter saying whether you are enrolled; if approved, up to a 90-day supply ships automatically and refills continue at no cost through the end of the calendar year. GSK does not publish a review time.
- Part D patients must re-apply to GSK each calendar year after again spending $600.
- Extra Help: Social Security notifies you by mail; if approved, your Part D plan applies the lower copays.
-
Step 7 — If the program is closed or you don't qualify
Do not stop at "closed" or "denied":
- Sign up for TotalAssist and HealthWell alerts so you hear when a COPD or Asthma fund reopens — there is no waitlist or queue.
- If you are short of GSK's $600 spending rule, keep your Part D statements: once your prescription spending crosses $600 later in the year, you can apply.
- Apply for Extra Help even if you think you earn too much — the limits are higher than many people expect.
- Ask your doctor whether another maintenance inhaler on your plan's preferred tier would work for you, or about a formulary exception; compare Part D plans in the fall — Trelegy's tier differs from plan to plan.
- Use the Medicare Prescription Payment Plan to spread this year's costs over monthly payments.
- Call Vernal Medicare — we'll go through every route above with you, free.
What you'll need
Only items the programs above actually ask for. Gather these before you start.
- Medicare card and your Part D or Medicare Advantage drug-plan card — plan name, member ID and group number
- Prescription details — medication name, strength and dose; prescriber name, office phone and address
- Diagnosis and date of diagnosis — TotalAssist needs the exact date if diagnosed within the past 6 months
- Household size and annual household income — and proof — tax return, Social Security or pension statements, or pay stubs
- Part D Explanation of Benefits showing $600 paid for prescriptions this year — GSK PAP — all pages of the most recent statement
- Copy of your Part D drug-plan card and your Medicare Beneficiary Identifier — GSK PAP — do not send the original card
- Signed original prescription for Trelegy — GSK PAP — or faxed directly from the prescriber's office with a cover sheet
Could Medicare Extra Help reduce your Trelegy Ellipta costs?
Extra Help is not a grant for Trelegy Ellipta. It is a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription — so it is worth checking even when a charitable fund is closed, because it does not depend on fund balances.
For Trelegy, Extra Help matters more than usual: the charity funds are closed and GSK's program requires you to spend $600 first. Extra Help has no such gate, and it lowers the copay on every covered drug — including the rescue inhaler you use alongside Trelegy.
In 2026, people with full Extra Help generally pay no more than $12.65 for a covered brand-name drug. Income must be below about $23,940 a year for one person ($32,460 for a couple) and countable resources under $18,090 ($36,100 for a couple). Apply free through Social Security — online, by phone at 1-800-772-1213, or in person — and never pay anyone to apply for you.
Extra Help explained (Utah) · Check if you might qualify · Medicare Savings Programs · All help paying for Medicare
Government program
Medicare Extra Help (Part D Low-Income Subsidy)
Medicare / Social Security Administration
Status: Year-round federal program (figures for 2026)
Not a grant for one drug — a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription.
If you have Medicare: For people with Medicare Part D or a Medicare Advantage drug plan who have limited income and resources.
What it can cover: Part D premium and deductible (often to $0) and reduced copays — generally no more than $12.65 for a covered brand-name drug in 2026 with full Extra Help.
Who may qualify
- Income below 150% of the federal poverty level — about $23,940 a year for one person or $32,460 for a married couple in 2026.
- Countable resources (savings, investments — not your home or car) limited to $18,090 for an individual or $36,100 for a married couple living together in 2026 (Medicare.gov figures, which include a burial-expense allowance).
- Automatic if you have Medicaid, Supplemental Security Income (SSI), or a Medicare Savings Program.
What the application asks for
- Social Security number and Medicare number
- Income (Social Security, pensions, wages) for you and a spouse you live with
- Value of savings, investments and other countable resources
How to apply
You (or someone helping you) apply free through Social Security — online, by phone, or at a Social Security office. There is never a fee to apply.
Key terms on this page
- Patient assistance program (PAP)
- A manufacturer program that provides its medication free or at low cost to people who meet income and insurance rules. Many PAPs accept Medicare Part D enrollees; each sets its own criteria.
- Copay card / savings card
- A manufacturer discount for commercially insured patients. Federal anti-kickback rules mean these cards generally cannot be used with Medicare, Medicaid or other government insurance.
- Charitable copay grant
- Money from a nonprofit foundation (for example HealthWell or Patient Advocate Foundation) that pays eligible copays or coinsurance for a specific diagnosis. A drug can be listed while the fund is closed to new applicants.
- Federal poverty level (FPL)
- A federal income measure that assistance programs use as a yardstick — "300% of FPL", "500% of FPL". The percentage is a rule, but the dollar figure behind it comes from a table each program publishes itself, built on a chosen year of the HHS poverty guidelines. Two programs can quote the same percentage in the same year and still list different dollar limits; compare each program against its own table, not against another program.
- Medicare Extra Help
- The Part D Low-Income Subsidy: a Medicare program that lowers or eliminates Part D premiums, deductibles and copays for beneficiaries with limited income and resources. You apply through Social Security.
- Maximum Fair Price (MFP)
- The price Medicare negotiated for a selected drug under the Medicare Drug Price Negotiation Program. It applies to Part D plans, not to the pharmacy cash price, and it lowers what plans and enrollees pay for that drug.
Related medication assistance guides
Frequently Asked Questions
Does Medicare cover Trelegy Ellipta?
Is there a Trelegy patient assistance program for people on Medicare?
Can I use the Trelegy coupon with Medicare?
Is there a charitable grant for Trelegy right now?
Is there a generic for Trelegy Ellipta?
What is the Medicare negotiated price for Trelegy?
What happens if the fund is closed?
Sources
- Trelegy Ellipta prescribing information (DailyMed) — U.S. National Library of Medicine (2026-08-26)
- GSK Patient Assistance Program — eligibility for people with Medicare Part D — GSK Patient Access Programs Foundation (2026-08-26)
- GSK Patient Assistance Program — non-vaccine application (PDF) — GSK Patient Access Programs Foundation (2026-08-26)
- GSK pricing information — Trelegy — GSK (2026-08-26)
- Trelegy savings offer — eligibility requirements and terms — GSK (2026-08-26)
- Trelegy Ellipta — savings and support — GSK (2026-08-26)
- GSK coupons and free-trial offers — GSK (2026-08-26)
- GSK Direct to You — cash-pay pharmacy program — GSK (2026-08-26)
- Negotiated prices for initial price applicability year 2027 (fact sheet) — CMS (2026-08-26)
- Medicare Drug Price Negotiation Program — selected drugs and negotiated prices — CMS (2026-08-26)
- Your Medicare in 2026: what you need to know — Medicare.gov (2026-08-26)
- Help with drug costs (Extra Help) — Medicare.gov (2026-08-26)
- TotalAssist — Chronic obstructive pulmonary disease (COPD) fund — Patient Advocate Foundation (2026-08-26)
- TotalAssist — Asthma fund — Patient Advocate Foundation (2026-08-26)
- TotalAssist — COPD health equity fund — Patient Advocate Foundation (2026-08-26)
- TotalAssist approved medication index — Patient Advocate Foundation (2026-08-26)
- Get notified when a fund opens — TotalAssist — Patient Advocate Foundation (2026-08-26)
- HealthWell Foundation — Asthma fund — HealthWell Foundation (2026-08-26)
- HealthWell Foundation — Chronic Obstructive Pulmonary Disease – Medicare Access fund — HealthWell Foundation (2026-08-26)
- HealthWell disease funds (status list) — HealthWell Foundation (2026-08-26)
- Good Days — diseases covered — Good Days (2026-08-26)
- Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons — HHS Office of Inspector General (2026-08-26)
Having trouble figuring out your prescription costs?
If you live in Vernal or the Uintah Basin, Vernal Medicare can help you understand your Medicare prescription coverage and where to look for Trelegy Ellipta assistance — free, no pressure. We don't award grants or decide eligibility; the programs above do. We help you find and apply to the right ones.